November 22, 2024
TOPLINE: Death rates for patients aged < 50 years with early-onset colorectal cancer (EOCRC) are higher in native Hawaiian and Other Pacific Islander individuals and non-Hispanic […]
November 22, 2024
TOPLINE: Women exposed to drinking water contaminated with high levels of synthetic chemicals known as perfluoroalkyl substances (PFAS) are not at an elevated risk for hormone […]
November 22, 2024
The role of adjuvant immunotherapy in triple-negative breast cancer (TNBC) remains uncertain. Standard therapy for TNBC includes neoadjuvant pembrolizumab with chemotherapy followed by pembrolizumab, with or […]
November 21, 2024
The U.S. Food and Drug Administration (FDA) has approved zanidatamab (Ziihera, Jazz Pharmaceuticals, Inc.) as monotherapy for previously treated, unresectable or metastatic HER2-positive biliary tract cancer […]
November 21, 2024
TOPLINE: The Profile for the Omission of Local Adjuvant Radiation (POLAR) biomarker, a 16-gene molecular signature, can help predict locoregional recurrence in patients with ER-positive early […]
November 21, 2024
The national survival rate for lung cancer has increased by 26% in the past 5 years, to 28.4% of all cases, according to a new report […]
November 20, 2024
Clear cell renal cell carcinoma (RCC) comprises 80% of all primary kidney malignancies and causes 90% of kidney cancer deaths. But it is notoriously tough to […]
November 20, 2024
The National Comprehensive Cancer Network (NCCN) has expanded two cancer genetic risk assessment guidelines to meet the growing understanding of hereditary cancer risk and use of […]
November 19, 2024
TOPLINE: The increase in incidence of pancreatic cancer among young Americans is largely due to improved detection of early-stage endocrine cancer, not an increase in pancreatic […]